Stock AVBP ARRIVENT BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases ArriVent BioPharma, Inc.

Equities

AVBP

US04272N1028

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-25 EDT 		5-day change 1st Jan Change
17.48 USD -2.13% Intraday chart for ArriVent BioPharma, Inc. -5.56% 0.00%
06-24 ArriVent BioPharma, Inc.(NasdaqGM:AVBP) added to S&P Global BMI Index CI
06-05 ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
AQ
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
AQ
ArriVent BioPharma Reports First Quarter 2024 Financial Results
AQ
ArriVent Appoints Kristine Peterson to its Board of Directors
AQ
InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
AQ
ArriVent BioPharma Reports Full Year 2023 Financial Results
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVBP Stock
  4. News ArriVent BioPharma, Inc.
  5. Press Releases